Close Menu

FDA

In Print: Mar 3, 2009

Premium

Microarray-Related Papers of Note, February 2009

Georgia Biotech Tort-Shield Bill, Michigan 'Cluster of Innovation,' Maryland Nanobiotechnology Grants, North Carolina Biotechnology Center, Solano Economic Development Corp., Hong Kong Stimulus Package

The integration of ADMETRx's ADME evaluation and CeeTox's toxicity screening during drug discovery and lead optimization will help pharmaceutical and biotech companies efficiently improve their drug discovery decision making capabilities, a CeeTox official told CBA News.

The agency will use the mass spec system in its ARS service to develop screens for drugs in livestock and poultry.

Mari Baker is leaving Navigenics, Andrew von Eschenbach has joined a consulting firm, Jay Flatley takes a seat on Helixis' board, and more.

The molecular diagnostics developer's full-year sales swelled 16 percent, as it plans to file for regulatory clearance for a variety of tests.

Industry Briefs: Feb 26, 2009

Premium

Mosaiques, Bruker, Kinaxo, Xencor, CSL, Hybrigenics, Adlyfe, Wyeth

In the wake of the stimulus boost, the omnibus bill kicks off 2009 funding talks as the 2010 process is about to get underway.

Clinical Data will use the funds to support late-stage development of two of its drugs.

As part of the arrangement, Columbia and the University of Nebraska-Lincoln signed an inter-institutional agreement that makes Columbia the lead on patent prosecution and negotiations, but gives both universities and their faculty inventors an undisclosed equity stake in the company.

Pages

A South African university has told the Wellcome Sanger Institute to return DNA samples it has from indigenous African communities, The Times reports.

The University of California, Berkeley's Rasmus Nielsen and Xinzhu Wei have retracted their CCR5 gene paper due to a technical artifact.

 

University of Virginia researchers are exploring a genetic risk test to gauge type 1 diabetes risk, NPR reports.

In PNAS this week: researchers compare two high-grade neuroendocrine lung cancers, height among ancient Europeans, and more.